Subscribe

IDEAS / Tickers

AZN

AstraZeneca

Uber’s Failed Breakdown and SharkNinja’s $92 Breakout Test

Patrick Dunuwila and Sam Gatlin favored Uber’s recovery and SharkNinja’s tight consolidation. AstraZeneca also had a strong trend, but its approach to a target made a fresh entry less appealing.

Recorded Stock Market TV Editorial

Search ideas